Please use this identifier to cite or link to this item: http://148.72.244.84:8080/xmlui/handle/xmlui/6321
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSafaa Shehab Ahmed-
dc.contributor.authorMohammed Abdul-Daim Saleh-
dc.date.accessioned2023-10-23T07:33:05Z-
dc.date.available2023-10-23T07:33:05Z-
dc.date.issued2022-
dc.identifier.citationhttps://dx.doi.org/10.24237/djps.1804.588Ben_US
dc.identifier.issn2222-8373-
dc.identifier.urihttp://148.72.244.84:8080/xmlui/handle/xmlui/6321-
dc.description.abstractChronic kidney disease-associated pruritus (CKD-aP) is a common, troubling, and in some cases a debilitating problem for patients with chronic kidney disease (CKD), end-stage renal disease (ESRD), as well as those maintained on hemodialysis (HD) or peritoneal dialysis (PD). This study aims to assess the serum complement 3 (C3), complement 4 (C4), and biochemical parameters levels in HD patients with CKD-aP. The research was performed between 4 th of October 2021 – 5 th of March 2022 on 60 HD patients, who suffer from CKD-aP, and 30 healthy controls in Baqubah Teaching Hospital-Ibn Sina Dialysis Center. The findings of our investigation revealed that levels of C3 and C4 were significantly decreased in HD patients with CKD-aP (57.83 ± 2.91 mg/dl and 14.59 ± 0.88 mg/dl, respectively) as compared to healthy controls (110.76 ± 2.20 mg/dl and 32.02 ± 1.09 mg/dl, respectively) (P = < 0.001).en_US
dc.description.sponsorshipdjps.uodiyala.edu.iqen_US
dc.language.isoenen_US
dc.publisherUniversity of Diyalaen_US
dc.subjectChronic kidney disease-associated pruritus, Uremic pruritus, Complement proteins.en_US
dc.titleEvaluation of Serum Complement Proteins and Biochemical Parameters in Patients with Chronic Kidney Disease-associated Pruritusen_US
dc.typeArticleen_US
Appears in Collections:مجلة ديالى للعلوم الاكاديمية / Academic Science Journal (Acad. Sci. J.)

Files in This Item:
File Description SizeFormat 
07754e26fb13a16b.pdf1.51 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.